Company: BA
Filing Date: 2025-07-29
Form Type: 10-Q
Source: 0000012927-25-000062
Chunk: 70

Company: BOEING CO
Filing Date: 2025-07-29
Form: 10-Q
Item: Item 1
Chunk 70
---
 Loss from operations on Unallocated items, eliminations and other ($451 million).

Loss from operations for the three months ended June 30, 2025, decreased by $914 million compared with the same period in 2024. The decrease in loss is primarily driven by BDS ($1,023 million), partially offset by an increase in Loss from operations on Unallocated items, eliminations and other ($401 million).

39

Core operating loss for the six and three months ended June 30, 2025, decreased by $1,546 million and $959 million compared with the same periods in 2024, primarily due to favorable changes in Segment operating earnings/(loss) as described above.

For information related to Postretirement Plans, see Note 13 to our Condensed Consolidated Financial Statements.

Unallocated Items, Eliminations and Other

The most significant items included in Unallocated items, eliminations and other (expense)/income are shown in the following table:

(Dollars in millions)Six months ended June 30Three months ended June 302025202420252024Share-based plans($51)$53 ($21)$43 Deferred compensation(80)(49)(85)(19)Amortization of previously capitalized interest(42)(46)(21)(23)Research and development expense, net(183)(188)(101)(99)Eliminations and other unallocated items(1,041)(716)(807)(536)Unallocated items, eliminations and other ($1,397)($946)($1,035)($634)

Share-based plans expense for the six and three months ended June 30, 2025, was $51 million and $21 million compared to share-based plans income of $53 million and $43 million for the same periods in 2024. The increase in share-based plans expense for the six and three months ended June 30, 2025 compared with the same period in 2024 was primarily due to the timing of corporate allocations.

Deferred compensation expense for the six months ended June 30, 2025, increased by $31 million compared with the same period in 2024 primarily driven by changes in our stock price. Deferred compensation expense for the three months ended June 30, 2025 increased by $66 million compared with the same period in 2024 primarily driven by changes in broad stock market conditions.

Research and development expense was largely unchanged during the six and three months ended June 30, 2025, compared with the same periods